This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Johnson & Johnson
Drug Names(s): JNJ38877605
Description: JNJ-38877605 is an inhibitor of mesenchymal epithelial transition (Met) kinase.
Additional information available to subscribers only: